Prosecution Insights
Last updated: April 19, 2026

Examiner: CRAIGO, WILLIAM A

Tech Center 1600 • Art Units: 1615 1621

This examiner grants 49% of resolved cases

Performance Statistics

49.2%
Allow Rate
-10.8% vs TC avg
780
Total Applications
+38.9%
Interview Lift
1228
Avg Prosecution Days
Based on 725 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
14.5%
§102 Novelty
40.2%
§103 Obviousness
22.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18537725 ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL Final Rejection FUJIFILM Corporation
18287475 BIORESORBABLE IMPLANT MATERIALS AND METHODS OF MAKING THE SAME Non-Final OA Georgia Tech Research Corporation
18145437 DISSOLVABLE MEDICAL DEVICE FOR PROMOTING HEALING OF WOUNDS Final Rejection Alcon Inc.
17996562 NALOXONE NANOPARTICLE COMPOSITIONS AND METHODS THEREOF Final Rejection THE TEXAS A&M UNIVERSITY SYSTEM
18684938 COMPOSITION FOR CARING FOR KERATIN MATERIALS Non-Final OA L'OREAL
18547934 COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18260276 ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS Final Rejection SOCIETE DES PRODUITS NESTLE S.A.
18288452 METHODS AND MATERIALS FOR TREATING A STROKE Non-Final OA THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
17790877 LOW ODOR HIGH LEVEL DISINFECTANT Final Rejection Medivators Inc.
18409605 SPRAYABLE STIMULI-RESPONSIVE MICRO-HYDROGELS FOR ADHESION PREVENTION AND ENHANCED TISSUE HEALING Final Rejection TEXAS MEDICAL CENTER
18400548 PREPARATION OF OCCLUSIVE DRESSINGS Non-Final OA KPR U.S., LLC
17623394 STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONS Non-Final OA Conopco, Inc., d/b/a UNILEVER
18380674 CARRIER FOR PROMOTING FENTON REACTION AND PREPARATION PROCESS AND USES THEREOF Non-Final OA National Tsing Hua University
18798718 OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF USE THEREOF, AND PREPARATION METHODS THEREOF Non-Final OA Allgenesis Biotherapeutics Inc.
18298348 Biocampatible and Biodegradable Anionic Hydrogel System Final Rejection BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
18678539 ORAL RIFAMYCIN SV COMPOSITIONS Non-Final OA COSMO TECHNOLOGIES LTD.
18713511 MEDICAL DEVICE Non-Final OA KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
18665039 PEPTIDE SLOW-RELEASE FORMULATIONS Non-Final OA CAMURUS AB
18706232 COMPOUND CONTAINING ASCORBIC ACID DERIVATIVE Non-Final OA DR'S CHOICE CO., LTD.
18245809 DRY FOAM COMPRISING AGAR-AGAR Final Rejection UNIVERSITE PARIS-SACLAY
17622379 SYNERGISTIC FUNGICIDE COMPOSITION Non-Final OA UPL LIMITED
18444429 COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF Non-Final OA HOLISTA BIOTECH SDN BHD
17283814 LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF Final Rejection ISP INVESTMENTS LLC
18407573 Lipstick Use And Application Non-Final OA Kinky Kitty, LLC
18402014 Device with Microstructure Mediated Absorption Profile Final Rejection BVW Holding AG
16098145 IMPROVED DRUG FORMULATIONS Final Rejection AustinPx, LLC
18553893 ANTIMICROBIAL ELUTING AIRWAY DEVICES Non-Final OA THE CHILDREN'S HOSPITAL OF PHILADELPHIA
18554502 SYSTEM OF MULTIPLE INTERLOCKING EMBEDMENT Non-Final OA CRAFT HEALTH PTE LTD
18230488 USE OF SYNERGISTIC COMPOSITIONS BASED ON ZOXAMIDE AND CYFLUFENAMID AS FUNGICIDES IN THE AGRONOMIC FIELD Non-Final OA Gowan Crop Protection Limited
18361506 GLOVE COMPRISING COATING Final Rejection SHANDONG INTCO MEDICAL PRODUCTS CO., LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month